NCT04879537 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Brown CA, Lilford RJ
The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006 Nov 8;6:54. doi: 10.1186/1471-2288-6-54.
Bundesärztekammer
Beschlussprotokoll des 121. Deutschen Ärztetages in Erfurt vom 08. bis 11.05.2018, Stand 08.06.2018.
Eatock D
Demografischer Ausblick für die Europäische Union 2019.
Fehr A, Lange C, Fuchs J, Neuhauser H, Schmitz R
Gesundheitsmonitoring und Gesundheitsindikatoren in Europa. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung; 2017.
Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ
The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015 Feb 6;350:h391. doi: 10.1136/bmj.h391. No abstract available.
Hoffmann F, Schmiemann G
Influence of age and sex on hospitalization of nursing home residents: A cross-sectional study from Germany. BMC Health Serv Res. 2017 Jan 19;17(1):55. doi: 10.1186/s12913-017-2008-7.
Jacobs K, Kuhlmey A, Greß S, Klauber J, Schwinger A
Pflege-Report 2018. Berlin, Heidelberg: Springer Berlin Heidelberg; 2018.
Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen
Bedarfsgerechte Steuerung der Gesundheitsversorgung. Gutachten 2018.
Sundmacher L, Fischbach D, Schuettig W, Naumann C, Augustin U, Faisst C
Which hospitalisations are ambulatory care-sensitive, to what degree, and how could the rates be reduced? Results of a group consensus study in Germany. Health Policy. 2015 Nov;119(11):1415-23. doi: 10.1016/j.healthpol.2015.08.007. Epub 2015 Sep 2.
Vossius C, Selbaek G, Saltyte Benth J, Bergh S
Mortality in nursing home residents: A longitudinal study over three years. PLoS One. 2018 Sep 18;13(9):e0203480. doi: 10.1371/journal.pone.0203480. eCollection 2018.

Optimized Acute Care for Geriatric Patients Using an Intersectoral Telemedical Cooperation Network - Around the Clock

Details for clinical trial NCT04879537

Clinical trial NCT04879537 - References